Najat Khan, CEO and President: Recursion Pharmaceuticals RXRX Planned sale · Filed 09/08

Trade details

Type: Planned sale notice
Stock: Recursion Pharmaceuticals RXRX
Person: Najat KhanCEO and President
Planned sale date: 26/09/08
Filed: 26/09/08

$78.8K to be sold

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 08/09~10/08

Najat Khan's recent trades

Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.4K
23,588 sh
$84.4K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.5K
23,588 sh
$84.5K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.8K
28,298 sh
$94.8K
Filed 03/11
Traded 03/09
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.7K
28,298 sh
$94.7K
Filed 03/09
Traded 03/09
Najat KhanChief R&D Commercial Officer
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$548.6K
124,403 sh
$548.6K
Filed 25/12/29
Traded 25/12/22

Najat Khan, CEO — plans to sell 22,408 sh of Recursion Pharmaceuticals RXRX · $78.8K · around 09/08 · 10b5-1 plan | Whalegun